FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
From - Diagnostic Testing & Emerging Technologies
Patients at risk for tuberculosis (TB) infection should be assessed with newer tests, including interferon-gamma release assays (IGRAs) and molecular diagnostics, according to…
From - Diagnostic Testing & Emerging Technologies
Epigenetic changes, measured by DNA methylation, may be a predictor of biological age, according to a study published in…
From - Diagnostic Testing & Emerging Technologies
Summer may be over but the fight against the mosquito-borne virus, Zika, continues in earnest. Locally-mosquito-transmitted cases in…
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first rapid molecular test for detection of antibiotic resistance directly from…